Vaccine Considerations in Patients with Cancer Receiving Systemic Anti-Cancer Therapy (including COVID-19)

Image
Three Association Logo's

A Joint CAPhO, ISOPP and BOPA Complimentary Webinar for Members. 

Monday, April 12, 2021

  • 12:00 PDT, 13:00 MDT, 13:00 CST, 15:00 EDT, 16:00 ADT, 20:00 BST

Join us for this members only complimentary panel discussion on the timely topic of vaccine considerations in cancer patients. All presenters are authors of the paper 'Clinician FAQs And Guidance On Covid-19 Vaccine For Patients Receiving Systemic Anti-Cancer Therapy (Sact) published by the UK Chemotherapy Board. 

Register now

The presenters for this 90 minute webinar are:

  • Deborah Enting, SACT Lead & Consultant Medical Oncologist, Guy’s & St Thomas’ NHS Foundation Trust
  • Rajinder Nijjar, Clinical Lead Pharmacist - Oncology, Barts Health NHS Trust 
  • Calum Polwart, Specialist Pharmacist - Oncology, South Tees Hospitals NHS Foundation Trust 
  • Nisha Shaunak, Lead Pharmacist - Oncology, Guy’s & St Thomas’ NHS Foundation Trust 

Registration is open to all paid members of CAPhO, ISOPP and BOPA.  

Not a member of CAPhO, ISOPP or BOPA? Join now by visiting your respective association's website as follows:

Canadian Association of Pharmacy in Oncology (CAPhO)

International Society of Oncology Pharmacy Practitioners (ISOPP)

British Oncology Pharmacy Association (BOPA)

 

Photo of Deborah Enting
Photo of Deborah Enting
Deborah Enting
Consultant Medical Oncologist / Honorary Senior Lecturer , Guy's and St Thomas' NHS Foundation Trust / King's College London — International

Deborah Enting is a Consultant Medical Oncologist at Guy's and St Thomas' NHS Foundation Trust, and an Honorary Senior Lecturer at King's College London. She specialises in the treatment of Urological Cancers and the systemic treatment (chemotherapy, immunotherapy and targeted therapies) for Bladder, Prostate, Kidney and Testicular cancers. Dr Enting undertook her medical training at the University of Groningen in The Netherlands and trained in Medical Oncology at Guy's and St George's Hospitals. She was a research fellow at the Department of Immunobiology at King's College London and in collaboration with colleagues of the Translational Oncology Urology Research (TOUR) group at King’s College London she works on tumour immune surveillance and bladder cancer research. She is the Clinical Lead for Systemic Anti-Cancer Therapies at Guy's Hospital . Together with colleagues within and outside her institution she has led on guidelines for COVID-19 vaccination in cancer patients which have been adopted nationally by the UK Chemotherapy Board.

Photo of Rajinder Nijjar
Photo of Rajinder Nijjar
Rajinder Nijjar
Clinical Lead Cancer Pharmacist / Cancer Commissioning Pharmacist, Barts Health NHS Trust / NHS England — International

Raj has specialised in Cancer for over 20 years. Currently she has a 50:50 split role with Barts Health NHS Trust and NHS England.

“My role at the Trust encompasses all the governance aspects involved in the introduction of new cancer related treatments including implementing any National Policy on cancer drugs. 
I am the lead Intrathecal Chemotherapy Trainer and also a Non-Medical Prescriber actively reviewing and prescribing for GI Oncology patients.
I was the Head of Chemotherapy for over ten years, taking the Trust though multiple successful chemotherapy Peer Reviews.
Away from work I run marathons and a proud six star finisher!”

Photo of Calum Polwart
Photo of Calum Polwart
Calum Polwart
Specialist Pharmacist Oncology , South Tees NHS Foundation Trust & Cancer Commissioning Pharmacist at NHSE/I (North East region) — International

He has worked in oncology pharmacy for over 20 years, and currently runs a number of chemotherapy prescribing clinics across 5 hospitals in the North East of England.  He is a self-proclaimed geek with a keen interest in data and evidence based practice.  He is well known for having an opinion on most things and couldn’t help but get involved in the development of national guidance on vaccines with SACT.

Photo of Nisha Shaunak
Photo of Nisha Shaunak
Nisha Shaunak
Lead Pharmacist for Cancer Services , Guy’s & St Thomas NHS Foundation Trust & Cancer Commissioning Pharmacist at NHSE/I (London Region) — International

Nisha is the Lead Pharmacist for Cancer Services at Guy’s & St Thomas NHS Foundation Trust & Cancer Commissioning Pharmacist at NHSE/I (London Region). She has worked in oncology for over 20 years, both in the NHS & private sector. Over the years, she has set up and worked in non-medical prescribing chemotherapy clinics for breast cancer patients. In her current role, she oversees the governance and strategic delivery of all systemic anti-cancer therapy services at the Trust and she is a wider member of the pharmacy executive team. More recently, she has been supporting the implementation of the covid-19 vaccination rollout with the pharmacy team at the Trust. Following various discussions, she has worked with her multi-disciplinary panel colleagues to develop a national FAQ document endorsed by the UK Chemotherapy Board to provide consistent clinician advice for SACT patients receiving the covid-19 vaccination. This document has evolved and been updated as more data and guidance has been made available. She has a special interest in Genomics and Advanced Therapy Medicinal Products (ATMPs) and is involved with regional & national working groups to develop and shape this for the future.